Zai Lab Ltd ZLAB
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-09-28
Zai Lab Ltd statistics & valuation
Market cap$16.4B
P / S35.7×
P / B23.0×
Net margin-38.1%
Return on equity-24.5%
FCF margin-34.5%
Return on capital-30.3%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | 66.6% | — | — |
| Operating margin | -49.9% | -70.7% | -137.4% | -188.0% | -485.1% | -616.4% | -1564.9% | -109897.7% | — | — |
| Net margin | -38.1% | -64.4% | -125.5% | -206.1% | -488.2% | -549.3% | -1502.3% | -107810.1% | — | — |
| FCF margin | -34.5% | -55.3% | -77.0% | -182.4% | -393.3% | -462.0% | -1517.5% | -83374.4% | — | — |
| Return on assets | -15.0% | -21.7% | -32.3% | -36.3% | -43.8% | -20.7% | -54.9% | -46.1% | -20.2% | -42.2% |
| Return on equity | -24.5% | -30.6% | -42.0% | -42.4% | -51.1% | -23.0% | -66.2% | -55.4% | -21.4% | 72.8% |
| Current ratio | 2.45 | 3.51 | 4.63 | 8.04 | 7.78 | 12.40 | 6.27 | 5.51 | 19.11 | 16.25 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.